舒泰神：STSA-1002注射液在急性呼吸窘迫综合征方向的临床试验首例已入组

Group 1 - The first patient has been enrolled in the clinical trial for STSA-1002 injection aimed at acute respiratory distress syndrome, with registration number CTR20253968 [2] - The enrollment has been publicly announced on the CDE platform [2] - The company will provide updates on the research and development progress through regular reports and project announcements [2]